Cancer Drug Resistance
All Journals
Search
Log In
Editor-in-Chief:
Godefridus J. Peters
Indexing:
ESCI
,
PMC
,
Scopus
,
CAS
,
CNKI
,
Dimensions
,
Lens
,
Embase
,
ASCI
,
Journal Rank:
Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 [Pharmacology(medical)]
Median time to first editorial decision:
9 days
Journal Flyer
Hot Keywords
Resistance
Drug delivery
Nanomedicine
Tumor microenvironment
Immune checkpoint inhibitors
Target therapy
Immunotherapy
Radiotherapy
Ferroptosis
PARP inhibitors
MYC
ABC transporters
Autophagy
Metabolism
Mechanisms
Precision medicine
Extracellular vesicles
Stem cell
Biomarker
Ovarian cancer
Renal cell carcinoma
Prostate cancer
Breast cancer
Colorectal cancer
Myeloid leukemia
Non-small cell lung cancer
Pancreatic cancer
Head and neck cancer
Squamous cell carcinoma
Mitochondria
Home
About
About the Journal
Aims and Scope
Editorial Policies
Editorial Board
Early‑Career Editorial Board
News
Journal History
Partners
Advertise
Contact Us
Publish with us
For Authors
Author Instructions
Article Processing Charges
Editorial Process
Manuscript Templates
Submit a Manuscript
For Reviewers
Peer Review Guidelines
Articles
All Articles
Editor’s Choice
Articles with Video Abstracts
Video Abstract Guidelines
Special Topics
All Special Topics
Ongoing Special Topics
Completed Special Topics
Special Topic Ebooks
Special Topic Guidelines
Special Collections
Volumes
Features
Webinars
Interviews
Home
Articles
Special Topics
Volumes
Webinars
Videos
Menu
Cancer Drug Resistance
Search
Submit
Editor-in-Chief:
Godefridus J. Peters
Journal Rank:
Impact Factor 2024: 5.2 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 [Pharmacology(medical)]
Median time to first editorial decision:
9 days
Home
Articles
Special Topics
Volumes
Webinars
Videos
Menu
Home
Volumes
Volume
Table of Contents (8 articles)
Circular RNA hsa-circ-0001030 suppresses proliferation and cisplatin tolerance in TSCC via interaction with PKM2
Haojie Yang, ... Fengtao Ji
View Full-Text
Download PDF
Identification of antibody-drug conjugate payloads that are substrates of ATP-binding cassette drug efflux transporters
Jacob S. Roth
, ... Matthew D. Hall
View Full-Text
Download PDF
Novel anti-tumor strategies: targeting the crosstalk between cancer stem cells and cancer-associated fibroblasts to resist drug resistance
Yang Shen, ... Chuan Xu
View Full-Text
Download PDF
TROP2-targeting antibody–drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms
Pilar Eroles, ... Víctor Lago
View Full-Text
Download PDF
Evaluation of intracellular nucleotide pools in peripheral blood and bone marrow mononuclear cells and their association with frontline intensive chemotherapy response rates in AML patients
Maël Heiblig, ... Christelle Machon
View Full-Text
Download PDF
Extracellular vesicles shed by multidrug resistant cells contribute to the identification of SRC inhibitors as chemosensitizers in non-small cell lung cancer
Bárbara Polónia, ... M. Helena Vasconcelos
View Full-Text
Download PDF
From EGFR PTM network to TKI resistance: spatial subtypes and targeting in lung cancer
Birou Lai, ... Badrul Hisham Yahaya
View Full-Text
Download PDF
Conjugated oligoelectrolytes overcome cancer drug resistance by dual-mode lysosomal membrane disruption
Lingna Wang, ... Bing Wang
View Full-Text
Download PDF
Actions for 0 selected articles
Download PDFs >
Cancer Drug Resistance
ISSN 2578-532X (Online)
[email protected]
Navigation
Contact Us
Sitemap
Follow Us
LinkedIn
Twitter
WeChat
Navigation
Contact Us
Sitemap
Committee on Publication Ethics
https://members.publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/
Committee on Publication Ethics
https://members.publicationethics.org/members/cancer-drug-resistance
Portico
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/